UBS Keeps Buy Rating, Raises PT to $31 from $28 on Abbott Laboratories.

miércoles, 14 de enero de 2026, 11:31 am ET1 min de lectura
ABT--
DAN--

UBS Keeps Buy Rating, Raises PT to $31 from $28 on Abbott Laboratories.

UBS Keeps Buy Rating, Raises PT to $31 from $28 on Abbott Laboratories.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios